PAD4-generated citrullinated histones are triggers for autoinflammation in cryopyrin-associated periodic syndrome

Bregje Christiaenssen1, Silke Mortelmans1, Siham Baghli1

  • 1Cell Death Signaling Laboratory, Department of Biomedical Sciences, Infla-Med Centre of Excellence, University of Antwerp, Antwerp, Belgium.

Insights

Cryopyrin-associated periodic syndromes (CAPS) involve autoinflammation driven by NLRP3 variants. Neutrophil extracellular traps (NETs) containing citrullinated histone 3 (CitH3) trigger IL-1β secretion, revealing new therapeutic targets for CAPS.

Area of Science:

  • Immunology
  • Genetics
  • Molecular Biology

Background:

  • Cryopyrin-associated periodic syndromes (CAPS) are autoinflammatory diseases linked to NLRP3 gene variants.
  • NLRP3 inflammasomes typically mediate IL-1β secretion via Gasdermin D (GSDMD).

Purpose of the Study:

  • To investigate the mechanisms of autoinflammation in CAPS, particularly the role of GSDMD-independent pathways.
  • To identify novel triggers and mediators of IL-1β secretion in CAPS.

Main Methods:

  • Utilized mice models with ubiquitous and neutrophil-specific Nlrp3A350V expression, including GSDMD-deficient and GSDME-deficient variants.
  • Analyzed neutrophil extracellular traps (NETs), citrullinated histone 3 (CitH3), and IL-1β secretion in macrophages and monocytes from mice and CAPS patients.
  • Investigated the role of protein arginine deiminase-4 (PAD4) in CitH3 release and its impact on autoinflammation.

Main Results:

  • GSDMD deletion did not prevent autoinflammation in Nlrp3A350V mice, indicating GSDMD-independent pathways.
  • CitH3-NETs were identified in inflamed skin and induced IL-1β secretion in a GSDMD-deficient context.
  • Blocking PAD4 inhibited CitH3 release and IL-1β secretion, while GSDME activation was crucial for pathology in GSDMD-deficient models.
  • PAD4 inhibition also ameliorated CAPS in GSDMD-dependent models.

Conclusions:

  • PAD4-mediated CitH3-NET release is a key driver of autoinflammation in CAPS.
  • Both GSDMD-dependent and GSDME-dependent pathways, triggered by CitH3-NETs, contribute to CAPS pathogenesis.
  • Targeting PAD4 and CitH3-NETs presents a potential therapeutic strategy for CAPS.

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...